NCT05619367 2025-12-23A Compassionate Use (CU) Program of OdronextamabRegeneron PharmaceuticalsAvailable
NCT04008524 2025-08-06A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological MalignanciesInstitute of Hematology & Blood Diseases Hospital, ChinaAvailable
NCT01370330 2025-07-22131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use ProtocolUniversity of California, San FranciscoAvailable